Our Mission & VisionHistory of THETATHETA News ArchiveTHETA Staff & CommunityContact Us
Health Modelling and Health EconomicsClinical ResearchHealth Policy and Ethics
Current StudiesCompleted Studies
THETA Quarterly NewsletterReportsWorking PapersPublicationsPresentationsTHETA KT Day & Symposium
Health Technology Assessment InstituteTHETA RoundsHTA Courses
HTA OrganizationsHTA ConferencesHTA Resources & Tools
This is the "Health Technology Assessment Institute" page of the "Welcome to Toronto Health Economics and Technology Assessment Collaborative" guide.
Alternate Page for Screenreader Users
Skip to Page Navigation
Skip to Page Content

Welcome to Toronto Health Economics and Technology Assessment Collaborative  

Last Updated: Apr 22, 2014 URL: http://theta.utoronto.ca/home Print Guide RSS Updates

Health Technology Assessment Institute Print Page
  Search: 
 
 

HEALTH TECHNOLOGY ASSESSMENT INSTITUTE

Health Technology Assessment for Decision Makers

HTA Institute 2014

July 14-16, 2014, Dalhousie University

THETA together with the Department of Community Health and Epidemiology at Dalhousie University in collaboration with the Institute of Health, Policy, Management and Evaluation, Leslie Dan Faculty of Pharmacy, and the CIHR-STIHR Health Care, Technology and Place Program will host the 2014 Health Technology Assessment Institute for Decision Makers.

The HTA Institute will bring together experts from a range of disciplines to provide attendees with pragmatic tools for HTA. This three-day intensive course will be useful to individuals who use HTA to make decisions relating to drugs, devices, and programs.

 

Contact Information

Anne Louise Pontigon Montgomery
p. 416-978-2067
f. 416-978-7350
e. annelouise.pontigon@utoronto.ca

Media sponsor: Longwoods Publishing

 

 

PROGRAM OVERVIEW


Key Features

  • Intensive three-day program
  • Theory bursts in lecture format to introduce and explain key concepts
  • Interactive sessions (small group learning and computer labs) to explore illustrative cases

Objectives

By the end of the course, participants will be able to review and assess:
  • Measures of evidence
  • Cost-effectiveness analyses
  • Approaches to integrating social and ethical issues

Curriculum Details

Day 1: Clinical Evidence
Day 1 will examine the nature of clinical evidence. Participants will learn the strengths and weaknesses of alternative study designs such as randomized controlled trials and observational research and understand how evidence strength is graded. We will also review common measures of effectiveness used in the medical literature so participants can understand the outcomes that are commonly reported in health technology assessments.
 
Day 2: Economic Evidence
Day 2 will explore the idea of value - the relationship between cost and health benefit. Participants will learn the key concepts and designs in cost effectiveness analysis, how to perform a simple analysis, and how to appraise and interpret cost effectiveness analyses that are part of health technology assessments.
 
Day 3: Social and Ethical Issues
Day 3 will explore the social and ethical issues arising in the use and appraisal of health technologies, and approaches to integrating evidence regarding these issues into HTA processes. Participants will learn about frameworks for integrating ethics and social values considerations into HTA appraisals; approaches to assessing stakeholder preferences through research evidence or stakeholder engagement; and accountability models for the conduct of HTA.

Back to Top
 

FACULTY

 
The Institute features leading HTA faculty from the Institute of Health Policy, Management & Evaluation and other departments at the University of Toronto. Faculty members for the Institute have included:
 
Ahmed Bayoumi, MD, MSc
Associate Professor, Department of Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto; CIHR/Ontario Ministry of Health and Long Term Care Applied Chair in Health Services and Policy Research
Wendong Chen, MD, PhD
Assistant Professor, Division of Clinical, Social, and Administrative Pharmacy, Leslie Dan Faculty of Pharmacy, University of Toronto; Investigator, Toronto Health Economics and Technology Assessment Collaborative, University of Toronto
Tammy Clifford, PhD
Chief Scientist, Canadian Agency for Drugs and Technologies in Health
Peter C. Coyte, PhD
Health Economics Professor, Institute of Health Policy, Management and Evaluation, University of Toronto and CHSRF/CIHR Chair in Health Services Research 2000-2010
 
Sharon Dell, MD, BEng, FRCPC
Associate Program Director, Clinical Epidemiology & Health Care Research Program, Institute of Health Policy, Management & Evaluation; Associate Professor, Department of Paediatrics, University of Toronto; Senior Associate Scientist, Child Health Evaluative Sciences; Pediatric Respirologist, The Hospital for Sick Children

Judith Fisher, PhD
Manager, Drug Technology Assessment, Pharmaceutical Services, Nova Scotia Department of Health and Wellness
Jennifer Gibson, PhD
Director, Partnerships and Strategy, Joint Centre for Bioethics; Assistant Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
Allan Grill, MD, CCFP, MPH
Assistant Professor, Department of Family and Community Medicine, University of Toronto; Chair, Committee to Evaluate Drugs, Ontario Ministry of Health and Long-Term Care; Member, pan-Canadian Oncology Drug Review Expert Review Committee (pERC); Provincial Primary Care Lead, Ontario Renal Network
Jeffrey Hoch, PhD
Director, Pharmacoeconomics Research Unit, Cancer Care Ontario; Scientist, Keenan Research Centre of the Li Ka Shing Knowledge Institute, St. Michael's Hospital; Associate Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
Joseph S. Kim, MD, PhD
Assistant Professor, Department of Medicine, University of Toronto; Division of Nephrology and Kidney Transplant Program, University Health Network
Murray Krahn, MD, MSc
F. Norman Hughes Chair in Pharmacoeconomics, University of Toronto; Director, Toronto Health Economics and Technology Assessment Collaborative; Member, Ontario Health Technology Advisory Committee
 
Janet Martin, PhD
Director, High Impact Technology Evaluation Centre (HiTEC), London Health Sciences Centre
Diane McArthur, MBA
Assistant Deputy Minister and Executive Officer, Ontario Public Drug Programs, Ontario Ministry of Health and Long-Term Care
Fiona Miller, PhD
Associate Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
 
Michelle Mujoomdar, PhD
Assistant Chief Scientist, Canadian Agency for Drugs and Technologies in Health

Mike Paulden, MSc, MA (Cantab)
Research Associate, Toronto Health Economics and Technology Assessment Collaborative, University of Toronto

Petros Pechlivanglou, PhD
Post-Doctoral Fellow, Toronto Health Economics and Technology Assessment Collaborative, University of Toronto
Beate Sander, PhD
Health Economist, Public Health Ontario and Assistant Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
Prakesh Shah, MD, MSc, MBBS, DCH, MRCP, FRCPC
Associate Professor, Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto
 
Vibhuti Shah, MD MRCP
Assistant Professor, Department of Paediatrics, University of Toronto; Staff Neonatologist, Mt. Sinai Hospital

Nancy Sikich, MSc
Clinical Epidemiologist, Health Quality Ontario

Lillian Sung, MD
Assistant Professor, Department of Paediatrics, University of Toronto; Scientist-track Investigator, Child Health Evaluative Sciences; Staff Physician, Department of Haematology/Oncology, The Hospital for Sick Children

Anna Taddio, PhD
Associate Professor, Leslie Dan Faculty of Pharmacy, University of Toronto; Senior Associate Scientist, Child Health Evaluative Sciences; Pharmacist, The Hospital for Sick Children

Amy Tawfik, PhD (c)
Doctoral Candidate, Leslie Dan Faculty of Pharmacy, University of Toronto

Back to Top
 

FEES, REGISTRATION & ACCREDITATION

Fees & Registration

Course Fee: TBA
Registration Opens: April 15, 2014
Registration Deadline: July 4, 2014
Maximum Registration: 34 participants
 
The University maintains program effectiveness by limiting the program numbers to 34 participants and requires a minimum of 21 participants. Registration will be accepted on a first come basis. It will be open until the registration deadline or until capacity is reached. Please book early.
The course fee includes tuition fee, all study materials, and food (breakfast, break refreshments and lunch for three days, and the Thursday social/dinner).
 
Registration: You can register online or send a printed online registration form via mail (for cheque payments only). Registration will open on April 15th.
 
Payment: You can pay online with your credit card. We accept AMEX, VISA, or MC. You can also make a cheque payment. Please issue the cheque payable to the University of Toronto and send (together with a printed online registration form) by the registration deadline to the address below. Note that registration is finalized with payment.
 
HTA Institute 2013
Institute of Health Policy, Management & Evaluation
University of Toronto
155 College Street, Suite 425
Toronto, Ontario M5T 3M6
 
Cancellation: In the event of a cancellation before the course begins, the course fee will be refunded less $150 administration fee. A 50% refund will be issued for cancellations made by June 19th unless a substitution is arranged. Cancellations must be submitted in writing.

 

Accreditation

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, approved by the University of Toronto (19.5 credits).
 

 

PAST SESSIONS

HTA Institute 2013: Toronto
June 26-28, 2013 | Croft Chapter House, University College, University of Toronto
Download:
Brochure
 
HTA Institute 2012: China
September 12-14, 2012 | Peking University
The China National Health Development Research Center (CNHDRC) and the Toronto Health Economics and Technology Assessment Collaborative (THETA) together with the Institute of Health, Policy, Management and Evaluation, Leslie Dan Faculty of Pharmacy, and Health Care, Technology and Place Program at the University of Toronto hosted a session of the HTA for Decision Makers in Beijing, China. The course was well received with over 50 registrants from academic, industry, and local & central governments across China.
 
Faculty: Ahmed Bayoumi MD MSc, Wendong Chen MD PhD, Peter Coyte PhD, Murray Krahn MD MSc, and Fiona Miller PhD
Download: Poster | Agenda | Photos

 
HTA Institute 2012: Toronto
July 25-27, 2012 | University of Toronto
Download:
Brochure
 
 
HTA Institute 2011: Toronto
July 20-22, 2011 | University of Toronto
Download: Brochure
 
 
 
  • OUR PARTNERS
  • Health Quality Ontario
  • Cancer Care Ontario
  • Leslie Dan Faculty of Pharmacy at the University of Toronto
  • Toronto General Hospital
Description

Loading  Loading...

Tip